Evidence map›Paper›PMID 41735619›Full record

ArticleJournal of natural medicines2026

Meroterpenoids from the fruiting body of Albatrellus dispansus with inhibitory activities against Candida albicans budded-to-hyphal-form transition and biofilm formation.

Ayumu Hirabayashi, Sanae Kurakado, Fumihito Wakaura, Hiroaki Sasaki, Takashi Sugita, Kiyotaka Koyama, Kaoru Kinoshita

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of natural medicines, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ayumu HirabayashiDepartment of Pharmacognosy and Phytochemistry, Meiji Pharmaceutical University, Noshio 2-522-1, Kiyose-shi, Tokyo, 204- 8588, Japan.
Sanae KurakadoDepartment of Microbiology, Meiji Pharmaceutical University, Noshio 2- 522-1, Kiyose-shi, Tokyo, 204-8588, Japan.
Fumihito WakauraDepartment of Pharmacognosy and Phytochemistry, Meiji Pharmaceutical University, Noshio 2-522-1, Kiyose-shi, Tokyo, 204- 8588, Japan.
Hiroaki SasakiDepartment of Pharmacognosy and Phytochemistry, Meiji Pharmaceutical University, Noshio 2-522-1, Kiyose-shi, Tokyo, 204- 8588, Japan.
Takashi SugitaDepartment of Microbiology, Meiji Pharmaceutical University, Noshio 2- 522-1, Kiyose-shi, Tokyo, 204-8588, Japan.
Kiyotaka KoyamaDepartment of Pharmacognosy and Phytochemistry, Meiji Pharmaceutical University, Noshio 2-522-1, Kiyose-shi, Tokyo, 204- 8588, Japan.
Kaoru KinoshitaDepartment of Pharmacognosy and Phytochemistry, Meiji Pharmaceutical University, Noshio 2-522-1, Kiyose-shi, Tokyo, 204- 8588, Japan. kaoru@my-pharm.ac.jp.ORCID http://orcid.org/0000-0002-8508-1625

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Six novel meroterpenoids, dispanoic acids A-C (1-3), 2'-hydroxydaurichromanic acid (4), albatrellutin A (5), and dispanolactone (6), along with four known meroterpenoids, grifolin (7), grifolic acid (8), grifolin methyl ether (9), and grifolic acid methyl ether (10), were obtained by bioactivity-guided isolation from the n-hexane, CHCl

Indexed as

Antifungal AgentsBiofilmsCandida albicansFruiting Bodies, FungalHyphaeTerpenesMagnetic Resonance SpectroscopyMicrobial Sensitivity TestsMolecular StructureAntifungal AgentsTerpenesAlbatrellus dispansus Candida albicansBiofirmGrifolic acidGrifolinHyphal formMeroterpenoids

Identifiers

PMID41735619

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.